Page 28 - Molecular Engineering News Today

Tel Aviv University scientists have developed a new material that will enable pacemakers to charge using only the heartbeat, with no need for batteries. As well as immediate medical applications, researchers believe this piezoelectric material could also have a wider impact on clean technology.

Existing drug may be effective in treating SARS-CoV-2 Scientists from the University of Chicago have found that the drug masitinib may be effective in treating COVID-19. The drug, which has undergone several clinical trials for human conditions but has not yet received approval to treat humans, inhibited the replication of SARS-CoV-2, the virus that causes COVID-19, in human cell cultures and in a mouse model, leading to much lower viral loads. X-ray crystallography gave us a strong indication ...

The U.S. new cases 7-day rolling average are 55.8 % HIGHER than the 7-day rolling average one week ago and U.S. deaths due to coronavirus are now 12.3 % LOWER than the rolling average one week ago. Todays posts include: U.S. Coronavirus New Cases are 60,838 U.S. Coronavirus deaths are at 397 Illinois reporting six times more gamma variant cases than delta Mitch McConnell warns there could be LOCKDOWNS if more Americans dont get vaccinated as the Delta variant continues to wreak havoc Existing ...

Existing drug may be effective in treating COVID-19 A new University of Chicago study has found that the drug masitinib may be effective in treating COVID-19. The drug, which has undergone several clinical trials for human conditions but has not yet received approval to treat humans, inhibited the replication of SARS-CoV-2 in human cell cultures and in a mouse model, leading to much lower viral loads. Researchers at UChicagos Pritzker School of Molecular Engineering (PME), working with collabor...

AB Science SA (Euronext - FR0010557264 - AB) today announces publication of a peer-reviewed article titled ‘ Masitinib is a broad coronavirus 3CL inhibitor that effectively blocks replication of SARS-CoV-2 in the journal Science [1]. The article reports on research that identifies masitinib as a broad antiviral agent capable of treating SARS-CoV-2 (the virus that causes COVID-19), including demonstration of in vivo activity in mice, with efficacy maintained, in vitro, against SARS-CoV-2 va...

A spring day on the University of Washington campus.Dennis Wise Twenty scientists and engineers at the University of Washington are among the 38 new members elected to the Washington State Academy of Sciences for 2021, according to a July 15 announcement. New members were chosen for “their outstanding record of scientific and technical achievement, and their willingness to work on behalf of the Academy to bring the best available science to bear on issues within the state of Washington.” Cu...

 E-Mail IMAGE: Argonnes Jie Xu with her Polybot, an artificial intelligence-guided robot for autonomous electronic material discovery. view more  Credit: (Image by Xiewen Wen.) Today, Jie Xu has been named to MIT Technology Reviews prestigious annual list of 35 Innovators Under 35 in the Global category. Every year since 1999, the world-renowned media company has recognized a list of exceptionally talented technologists whose work has great potential to transform the world. Tim Maher, m...

Matthew Tirrell has been reappointed dean of the Pritzker School of Molecular Engineering. A pioneering researcher in biomolecular engineering and nanotechnology, Tirrell has led UChicago’s program in molecular engineering since its inception in 2011.

Kelly, a greyhound, was diagnosed with a fatal cancer in 2019  The dog received rounds of chemotherapy, but the treatment did not work  Kelly recently received a cancer vaccine made of her own cancer tumor  The dog is now in remission and is thriving, according to Kellys owner The vaccine stimulates the patients immune system to combat the cancer A similar therapeutic vaccine is being developed for humans with cancer  

Kelly the greyhounds fatal cancer is cured with vaccine Stacy Liberatore For Dailymail.com © Provided by Daily Mail MailOnline logo An 11-year-old greyhound that was diagnosed with cancer in 2019, is now in remission and thriving thanks to a new vaccine. Scientists at the University of Sydney treated the canine, named Kelly, using a sample from the tumor allows for a personalized treatment. This stimulates the patients immune system to combat the cancer, which is also method ...